Thematic Review Series: Functional Regulation of Lipid Homeostasis by microRNA: A big role for small RNAs in HDL homeostasis

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1161-1167

  Ouimet, Mireille ^a   Moore, Kathryn J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

High density lipoprotein; Lipid metabolism; MicroRNA; Post transcriptional gene regulation

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN RECEPTOR; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MICRORNA; MICRORNA 106B; MICRORNA 125A; MICRORNA 22; MICRORNA 223; MICRORNA 26; MICRORNA 455; MICRORNA 758; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SMALL UNTRANSLATED RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DYSLIPIDEMIA; EXTRACELLULAR SPACE; FATTY ACID OXIDATION; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; LIPID HOMEOSTASIS; LIPID TRANSPORT; LIPOPROTEIN SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RISK REDUCTION; RNA ANALYSIS; RNA TRANSPORT; SOMATIC CELL; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; GENE EXPRESSION REGULATION; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; PATHOLOGY;

ATHEROSCLEROSIS; CHOLESTEROL, HDL; CLINICAL TRIALS AS TOPIC; CORONARY DISEASE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; MICRORNAS;

EID: 84876814353     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R036327     Document Type: Review

References (47)

1. Boden, W. E. 2000. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: Assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86 : 19L-22L.
2. Lilly, S. M., and D. J. Rader. 2007. New targets and emerging therapies for reducing LDL cholesterol. Curr. Opin. Lipidol. 18 : 650-655.
3. Shah, P. K. 2007. Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: A novel therapeutic approach. Curr. Pharm. Des. 13 : 1031-1038.
4. Smith, J. D. 2010. Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis. Curr. Opin. Investig. Drugs. 11: 989-996.
5. Rader, D. J., and A. R. Tall. 2012. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat. Med. 18 : 1344-1346.
6. Ouimet, M., and Y. L. Marcel. 2012. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 32 : 575-581.
7. Krimbou, L., M. Marcil, and J. Genest. 2006. New insights into the biogenesis of human high-density lipoproteins. Curr. Opin. Lipidol. 17 : 258-267.
8. von Eckardstein, A., J. R. Nofer, and G. Assmann. 2001. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21 : 13-27.
9. Krieger, M. 1999. Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 68 : 523-558.
10. Wolkoff, A. W., and D. E. Cohen. 2003. Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 284 : G175-G179.
11. Beltowski, J. 2008. Liver X receptors (LXR) as therapeutic targets in dyslipidemia. Cardiovasc. Ther. 26: 297-316.
12. Khera, A. V., and D. J. Rader. 2010. Future therapeutic directions in reverse cholesterol transport. Curr. Atheroscler. Rep. 12 : 73-81.
13. Bartel, D. P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell. 136 : 215-233.
14. Zhu, H., and G. C. Fan. 2011. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am. J. Cardiovasc. Dis. 1 : 138-149.
15. Lee, Y., C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark, S. Kim, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature. 425 : 415-419.
16. Lund, E., S. Guttinger, A. Calado, J. E. Dahlberg, and U. Kutay. 2004. Nuclear export of microRNA precursors. Science. 303 : 95-98.
17. Chendrimada, T. P., R. I. Gregory, E. Kumaraswamy, J. Norman, N. Cooch, K. Nishikura, and R. Shiekhattar. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 436 : 740-744.
18. Gregory, R. I., K. P. Yan, G. Amuthan, T. Chendrimada, B. Doratotaj, N. Cooch, and R. Shiekhattar. 2004. The microprocessor complex mediates the genesis of microRNAs. Nature. 432 : 235-240.
19. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often fl anked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120 : 15-20.
20. Mah, S. M., C. Buske, R. K. Humphries, and F. Kuchenbauer. 2010. miRNA*: A passenger stranded in RNA-induced silencing complex? Crit. Rev. Eukaryot. Gene Expr. 20 : 141-148.
21. Curtis, H. J., C. R. Sibley, and M. J. Wood. 2012. Mirtrons, an emerging class of atypical miRNA. Wiley Interdiscip. Rev. RNA. 3 : 617-632.
22. Lagos-Quintana, M., R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12 : 735-739.
23. Esau, C., S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey, M. Pear, L. Watts, S. L. Booten, M. Graham, R. McKay, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 : 87-98.
24. Elmén, J., M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, M. Hedtjarn, J. B. Hansen, H. F. Hansen, E. M. Straarup, et al. 2008. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36 : 1153-1162.
25. Elmén, J., M. Lindow, S. Schutz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjarn, H. F. Hansen, U. Berger, et al. 2008. LNAmediated microRNA silencing in non-human primates. Nature. 452 : 896-899.
26. Lanford, R. E., E. S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. E. Munk, S. Kauppinen, and H. Orum. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327 : 198-201.
27. Jopling, C. L., M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow. 2005. Modulation of hepatitis C virus RNA abundance by a liverspecific microRNA. Science. 309 : 1577-1581.
28. Jopling, C. L., S. Schutz, and P. Sarnow. 2008. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe. 4 : 77-85.
29. Randall, G., M. Panis, J. D. Cooper, T. L. Tellinghuisen, K. E. Sukhodolets, S. Pfeffer, M. Landthaler, P. Landgraf, S. Kan, B. D. Lindenbach, et al. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. USA. 104 : 12884-12889.
30. Marquart, T. J., R. M. Allen, D. S. Ory, and A. Baldan. 2010. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA. 107 : 12228-12232.
31. Najafi-Shoushtari, S. H., F. Kristo, Y. Li, T. Shioda, D. E. Cohen, R. E. Gerszten, and A. M. Naar. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 328 : 1566-1569.
32. Rayner, K. J., Y. Suarez, A. Davalos, S. Parathath, M. L. Fitzgerald, N. Tamehiro, E. A. Fisher, K. J. Moore, and C. Fernandez-Hernando. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 328 : 1570-1573.
33. Rayner, K. J., C. C. Esau, F. N. Hussain, A. L. McDaniel, S. M. Marshall, J. M. van Gils, T. D. Ray, F. J. Sheedy, L. Goedeke, X. Liu, et al. 2011. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 478 : 404-407.
34. Rayner, K. J., F. J. Sheedy, C. C. Esau, F. N. Hussain, R. E. Temel, S. Parathath, J. M. van Gils, A. J. Rayner, A. N. Chang, Y. Suarez, et al. 2011. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121 : 2921-2931.
35. Horie, T., K. Ono, M. Horiguchi, H. Nishi, T. Nakamura, K. Nagao, M. Kinoshita, Y. Kuwabara, H. Marusawa, Y. Iwanaga, et al. 2010. MicroRNA-33 encoded by an intron of sterol regulatory elementbinding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl. Acad. Sci. USA. 107 : 17321-17326.
36. Allen, R. M., T. J. Marquart, C. J. Albert, F. J. Suchy, D. Q. Wang, M. Ananthanarayanan, D. A. Ford, and A. Baldan. 2012. miR-33 controls the expression of biliary transporters, and mediates statin-and diet-induced hepatotoxicity. EMBO Mol. Med. 4 : 882-895.
37. Horie, T., O. Baba, Y. Kuwabara, Y. Chujo, S. Watanabe, M. Kinoshita, M. Horiguchi, T. Nakamura, K. Chonabayashi, M. Hishizawa, et al. 2012. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE (α /α) mice. J. Am. Heart Assoc. 1 : E003376.
38. Marquart, T. J., J. Wu, A. J. Lusis, and A. Baldan. 2013. Anti-miR-33 therapy does not alter the progression of atherosclerosis in lowdensity lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 33 : 455-458.
39. Wijesekara, N., L. H. Zhang, M. H. Kang, T. Abraham, A. Bhattacharjee, G. L. Warnock, C. B. Verchere, and M. R. Hayden. 2012. miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes. 61 : 653-658.
40. Kim, J., H. Yoon, C. M. Ramirez, S. M. Lee, H. S. Hoe, and C. Fernandez-Hernando. 2012. MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp. Neurol. 235 : 476-483.
41. Ramirez, C. M., A. Davalos, L. Goedeke, A. G. Salerno, N. Warrier, D. Cirera-Salinas, Y. Suarez, and C. Fernandez-Hernando. 2011. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol. 31 : 2707-2714.
42. Sun, D., J. Zhang, J. Xie, W. Wei, M. Chen, and X. Zhao. 2012. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett. 586 : 1472-1479.
43. Wolf, A., B. Bauer, and A. M. Hartz. 2012. ABC transporters and the Alzheimer's disease enigma. Front. Psychiatry. 3 : 54.
44. Hu, Z., W. J. Shen, F. B. Kraemer, and S. Azhar. 2012. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol. Cell. Biol. 32 : 5035-5045.
45. Vickers, K. C., B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley. 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13 : 423-433.
46. Besler, C., T. F. Lüscher, and U. Landmesser. 2012. Molecular mechanisms of vascular effects of high-density lipoprotein: Alterations in cardiovascular disease. EMBO Mol. Med. 4: 251-268.
47. Zhang, L., D. Hou, X. Chen, D. Li, L. Zhu, Y. Zhang, J. Li, Z. Bian, X. Liang, X. Cai, et al. 2012. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA. Cell Res. 22 : 107-126.